Discover why starting HIV treatment promptly preserves immune function, prevents transmission, improves quality of life and ...

Olga Rivera Ballesteros from the Center for Infectious Medicine (CIM) at the Department of Medicine, Huddinge (MedH) is ...

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

An annual shot to protect against HIV infection has successfully passed an early safety trial, according to research ...

Researchers assessed epidemiologic trends of incident hepatitis C virus infection among patients with HIV infection engaged in care in the US.

Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against ...

Providing long-acting (LA) antiretroviral therapy (ART) to breastfeeding women with HIV who face adherence challenges may be ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

The project has four roving clinics that influencers are contracted to visit to brand HIV prevention as hip and ‘cool’ ...